HOTH - Hoth Therapeutics, Inc.

Stock Grade Analysis

General Rating

C+
Overall Score: 2/5
Multi-dimensional Scores
DCF: 4/5 ROE: 1/5 ROA: 1/5 D/E: 2/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

0

Strong Buy

5

Buy

0

Hold

0

Sell

0

Strong Sell

Buy

Consensus

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2025-01-07 Citigroup Buy Buy Hold $2.28 D. Boral says Hoth findings highlight HT-001 potential to '… TheFly
2024-10-16 H.C. Wainwright Buy Buy Hold $0.8865 H.C. Wainwright Reiterates Buy Rating on Hoth Therapeutics … StreetInsider
2024-10-11 Benchmark Speculative Buy Speculative Buy Hold $0.7389 Benchmark Reiterates Speculative Buy Rating on Hoth Therape… StreetInsider
2024-04-02 EF Hutton Buy Buy Hold $1.42 EF Hutton Reiterates Buy Rating on Hoth Therapeutics (HOTH)… StreetInsider
2023-09-14 EF Hutton Buy Buy Hold $1.76 EF Hutton Maintains Buy Rating for Hoth Therapeutics: Here'… Benzinga
2022-12-30 EF Hutton Buy Buy Hold $8.6881 Ardelyx To Rally 160%? Here Are 10 Other Price Target Chang… Benzinga